Literature DB >> 12424493

Effects of caffeine on learning and memory in rats tested in the Morris water maze.

M E M Angelucci1, C Cesário, R H Hiroi, P L Rosalen, C Da Cunha.   

Abstract

We studied some of the characteristics of the improving effect of the non-specific adenosine receptor antagonist, caffeine, using an animal model of learning and memory. Groups of 12 adult male Wistar rats receiving caffeine (0.3-30 mg/kg, ip, in 0.1 ml/100 g body weight) administered 30 min before training, immediately after training, or 30 min before the test session were tested in the spatial version of the Morris water maze task. Post-training administration of caffeine improved memory retention at the doses of 0.3-10 mg/kg (the rats swam up to 600 cm less to find the platform in the test session, P<=0.05) but not at the dose of 30 mg/kg. Pre-test caffeine administration also caused a small increase in memory retrieval (the escape path of the rats was up to 500 cm shorter, P<=0.05). In contrast, pre-training caffeine administration did not alter the performance of the animals either in the training or in the test session. These data provide evidence that caffeine improves memory retention but not memory acquisition, explaining some discrepancies among reports in the literature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424493     DOI: 10.1590/s0100-879x2002001000013

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  28 in total

1.  Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.

Authors:  Vasco C Sousa; Natália Assaife-Lopes; Joaquim A Ribeiro; Judith A Pratt; Ros R Brett; Ana M Sebastião
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

Review 2.  The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities.

Authors:  Claudio Da Cunha; Miriam Elizabeth Mendes Angelucci; Newton S Canteras; Susan Wonnacott; Reinaldo N Takahashi
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 3.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

4.  Coffee time: Low caffeine dose promotes attention and focus in zebrafish.

Authors:  Julia Ruiz-Oliveira; Priscila Fernandes Silva; Ana Carolina Luchiari
Journal:  Learn Behav       Date:  2019-09       Impact factor: 1.986

Review 5.  The Impact of Caffeine on the Behavioral Effects of Ethanol Related to Abuse and Addiction: A Review of Animal Studies.

Authors:  Laura López-Cruz; John D Salamone; Mercè Correa
Journal:  J Caffeine Res       Date:  2013-03

Review 6.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

7.  Concentration- and age-dependent effects of chronic caffeine on contextual fear conditioning in C57BL/6J mice.

Authors:  Rachel L Poole; David Braak; Thomas J Gould
Journal:  Behav Brain Res       Date:  2015-03-28       Impact factor: 3.332

8.  Chronic caffeine treatment prevents sleep deprivation-induced impairment of cognitive function and synaptic plasticity.

Authors:  Ibrahim A Alhaider; Abdulaziz M Aleisa; Trinh T Tran; Karem H Alzoubi; Karim A Alkadhi
Journal:  Sleep       Date:  2010-04       Impact factor: 5.849

9.  The role of adenosine in Alzheimer's disease.

Authors:  Anisur Rahman
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

10.  Regulation of cerebrospinal fluid production by caffeine consumption.

Authors:  Myoung-Eun Han; Hak-Jin Kim; Young-Suk Lee; Dong-Hyun Kim; Joo-Taek Choi; Chul-Sik Pan; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Jae-Bong Kim; Sae-Ock Oh
Journal:  BMC Neurosci       Date:  2009-09-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.